Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Villiger

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|September 18, 2010
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysisSimon Wandel, Peter Jüni, Britta Tendal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
T cell-regulated neutrophilic inflammation in autoinflammatory diseasesMonika Keller, Zoi Spanou, Patrick Schaerli, et al.
Patient Education and Counseling|May 11, 2010
Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trialKarin Niedermann, Rob A de Bie, Regula Kubli, et al.
Arthritis Care & Research|August 26, 2021
Mortality in ankylosing spondylitis according to treatment: comment on the article by Ben Shabat et alZhixiu Li, Mohammad K Khan, Peter M Villiger, et al.
Lancet (London, England)|March 9, 2016
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialPeter M Villiger, Sabine Adler, Stefan Kuchen, et al.
European Journal of Immunology|February 14, 2015
Blocking of LFA-1 enhances expansion of Th17 cells induced by human CD14(+) CD16(++) nonclassical monocytesEmmanuel Traunecker, Rui Gardner, João Eurico Fonseca, et al.
Swiss Medical Weekly|March 11, 2019
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in SwitzerlandJohannes von Kempis, Sabine Duetsch, Nicola Reuschling, et al.
Journal of Advanced Nursing|August 28, 2019
Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocolAgnes Kocher, Michael Simon, Andrew A Dwyer, et al.
Psychotherapy and Psychosomatics|November 2, 2002
Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure) - a brief method to assess sufferingStefan Büchi, Claus Buddeberg, Richard Klaghofer, et al.
Arthritis Research & Therapy|March 23, 2021
Vision loss in patients with giant cell arteritis treated with tocilizumabJennifer Amsler, Iveta Kysela, Christoph Tappeiner, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|September 18, 2010
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysisSimon Wandel, Peter Jüni, Britta Tendal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
T cell-regulated neutrophilic inflammation in autoinflammatory diseasesMonika Keller, Zoi Spanou, Patrick Schaerli, et al.
Patient Education and Counseling|May 11, 2010
Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trialKarin Niedermann, Rob A de Bie, Regula Kubli, et al.
Arthritis Care & Research|August 26, 2021
Mortality in ankylosing spondylitis according to treatment: comment on the article by Ben Shabat et alZhixiu Li, Mohammad K Khan, Peter M Villiger, et al.
Lancet (London, England)|March 9, 2016
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialPeter M Villiger, Sabine Adler, Stefan Kuchen, et al.
European Journal of Immunology|February 14, 2015
Blocking of LFA-1 enhances expansion of Th17 cells induced by human CD14(+) CD16(++) nonclassical monocytesEmmanuel Traunecker, Rui Gardner, João Eurico Fonseca, et al.
Swiss Medical Weekly|March 11, 2019
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in SwitzerlandJohannes von Kempis, Sabine Duetsch, Nicola Reuschling, et al.
Journal of Advanced Nursing|August 28, 2019
Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocolAgnes Kocher, Michael Simon, Andrew A Dwyer, et al.
Psychotherapy and Psychosomatics|November 2, 2002
Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure) - a brief method to assess sufferingStefan Büchi, Claus Buddeberg, Richard Klaghofer, et al.
Arthritis Research & Therapy|March 23, 2021
Vision loss in patients with giant cell arteritis treated with tocilizumabJennifer Amsler, Iveta Kysela, Christoph Tappeiner, et al.
Pageof 14